SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-022301
Filing Date
2020-11-03
Accepted
2020-11-03 07:30:25
Documents
15
Period of Report
2020-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K oxfd20201029_8k.htm   iXBRL 8-K 27607
2 EXHIBIT 99.1 ex_210146.htm EX-99.1 237996
7 ex_210146img001.jpg GRAPHIC 6560
  Complete submission text file 0001437749-20-022301.txt   427755

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20201103.xsd EX-101.SCH 3702
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20201103_def.xml EX-101.DEF 11953
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20201103_lab.xml EX-101.LAB 15972
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20201103_pre.xml EX-101.PRE 12162
8 EXTRACTED XBRL INSTANCE DOCUMENT oxfd20201029_8k_htm.xml XML 2657
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36200 | Film No.: 201281911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances